FDA — authorised 22 December 1971
- Application: ANDA080027
- Marketing authorisation holder: ALCON LABS INC
- Local brand name: ALCAINE
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
🇺🇸 Proxymetacaine in United States
FDA authorised Proxymetacaine on 22 December 1971
Marketing authorisation
Other Ophthalmology approved in United States
Frequently asked questions
Is Proxymetacaine approved in United States?
Yes. FDA authorised it on 22 December 1971.
Who is the marketing authorisation holder for Proxymetacaine in United States?
ALCON LABS INC holds the US marketing authorisation.